SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 16.80
+0.18 (1.05%)
Jun 27, 2025, 4:35 PM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 43.47 million as of June 27, 2025. Its market cap has increased by 131.28% in one year.
Market Cap
43.47M
Enterprise Value
43.26M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.80
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 43.47M, an increase of 176.40%. That is a compound annual growth rate of 13.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.30B |
| GSK plc | 56.46B |
| Haleon | 33.93B |
| Smith & Nephew | 9.63B |
| ConvaTec Group | 5.90B |
| Hikma Pharmaceuticals | 4.41B |
| HUTCHMED (China) | 1.89B |
| Oxford Nanopore Technologies | 1.30B |